These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34249421)

  • 1. BCAT1 knockdown-mediated suppression of melanoma cell proliferation and migration is associated with reduced oxidative phosphorylation.
    Zhang B; Xu F; Wang K; Liu M; Li J; Zhao Q; Jiang L; Zhang Z; Li Y; Chen H; Zhang J; Tang X; Zhang J
    Am J Cancer Res; 2021; 11(6):2670-2683. PubMed ID: 34249421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.
    Wang ZQ; Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Guillemette C; Gobeil S; Macdonald E; Vanderhyden B; Bachvarov D
    Oncotarget; 2015 Oct; 6(31):31522-43. PubMed ID: 26372729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function.
    Zhang L; Han J
    Biochem Biophys Res Commun; 2017 Apr; 486(2):224-231. PubMed ID: 28235484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Branched-chain amino acid transaminase 1 regulates glioblastoma cell plasticity and contributes to immunosuppression.
    Boskovic P; Wilke N; Man KH; Lichter P; Francois L; Radlwimmer B
    Neuro Oncol; 2024 Feb; 26(2):251-265. PubMed ID: 37769206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression.
    Qian L; Li N; Lu XC; Xu M; Liu Y; Li K; Zhang Y; Hu K; Qi YT; Yao J; Wu YL; Wen W; Huang S; Chen ZJ; Yin M; Lei QY
    Nat Metab; 2023 Jul; 5(7):1159-1173. PubMed ID: 37337119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defect of branched-chain amino acid metabolism promotes the development of Alzheimer's disease by targeting the mTOR signaling.
    Li H; Ye D; Xie W; Hua F; Yang Y; Wu J; Gu A; Ren Y; Mao K
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29802157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCAT1 promotes proliferation of endometrial cancer cells through reprogrammed BCAA metabolism.
    Wang P; Wu S; Zeng X; Zhang Y; Zhou Y; Su L; Lin W
    Int J Clin Exp Pathol; 2018; 11(12):5536-5546. PubMed ID: 31949641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of branched-chain amino acid aminotransferase (Bcat1/Eca39) in apoptosis.
    Eden A; Benvenisty N
    FEBS Lett; 1999 Aug; 457(2):255-61. PubMed ID: 10471790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCAT1 promotes tumor cell migration and invasion in hepatocellular carcinoma.
    Xu M; Liu Q; Jia Y; Tu K; Yao Y; Liu Q; Guo C
    Oncol Lett; 2016 Oct; 12(4):2648-2656. PubMed ID: 27698837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma.
    Zeng B; Zhang X; Zhao J; Wei Z; Zhu H; Fu M; Zou D; Feng Y; Luo H; Lei Y
    BMC Cancer; 2019 Jun; 19(1):609. PubMed ID: 31226958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids.
    Panosyan EH; Lasky JL; Lin HJ; Lai A; Hai Y; Guo X; Quinn M; Nelson SF; Cloughesy TF; Nghiemphu PL
    J Neurooncol; 2016 May; 128(1):57-66. PubMed ID: 26922345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCAT1 redox function maintains mitotic fidelity.
    Francois L; Boskovic P; Knerr J; He W; Sigismondo G; Schwan C; More TH; Schlotter M; Conway ME; Krijgsveld J; Hiller K; Grosse R; Lichter P; Radlwimmer B
    Cell Rep; 2022 Oct; 41(3):111524. PubMed ID: 36260995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia.
    Hattori A; Tsunoda M; Konuma T; Kobayashi M; Nagy T; Glushka J; Tayyari F; McSkimming D; Kannan N; Tojo A; Edison AS; Ito T
    Nature; 2017 May; 545(7655):500-504. PubMed ID: 28514443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCAT1: A risk factor in multiple cancers based on a pan-cancer analysis.
    Li GS; Huang HQ; Liang Y; Pang QY; Sun HJ; Huang ZG; Dang YW; Yang LJ; Chen G
    Cancer Med; 2022 Mar; 11(5):1396-1412. PubMed ID: 34984849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data mining of the expression and regulatory role of BCAT1 in hepatocellular carcinoma.
    Zou H; Liao M; Xu W; Yao R; Liao W
    Oncol Lett; 2019 Dec; 18(6):5879-5888. PubMed ID: 31788061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DOT1L histone methyltransferase regulates the expression of BCAT1 and is involved in sphere formation and cell migration of breast cancer cell lines.
    Oktyabri D; Ishimura A; Tange S; Terashima M; Suzuki T
    Biochimie; 2016 Apr; 123():20-31. PubMed ID: 26783998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of branched-chain aminotransferase 1 in driving glioblastoma cell proliferation and invasion varies with tumor subtype.
    Fala M; Ros S; Sawle A; Rao JU; Tsyben A; Tronci L; Frezza C; Mair R; Brindle KM
    Neurooncol Adv; 2023; 5(1):vdad120. PubMed ID: 37885806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCAT1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin.
    Zheng YH; Hu WJ; Chen BC; Grahn TH; Zhao YR; Bao HL; Zhu YF; Zhang QY
    Liver Int; 2016 Dec; 36(12):1836-1847. PubMed ID: 27246112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin Can Suppress Cell Proliferation Independent of the Cytosolic Branched-Chain Amino Acid Transferase 1 (BCAT1).
    Grankvist N; Lagerborg KA; Jain M; Nilsson R
    Biochemistry; 2018 Dec; 57(49):6762-6766. PubMed ID: 30427175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study.
    Wegermann K; Henao R; Diehl AM; Murphy SK; Abdelmalek MF; Moylan CA
    PLoS One; 2018; 13(9):e0204308. PubMed ID: 30265706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.